Human Monoclonal Antibodies

Human Monocolonal Antibodies: The Benefits of Humanization.- Cancer Immunotherapy: The Dawn of Antibody Cocktails.- IgM Natural Autoantibodies in Physiology and the Treatment of Disease.- Monoclonal Antibodies for the Treatment of Melanoma: Present and Future Strategies.- An Efficient Method to Generate Monoclonal Antibodies from Human B Cells.- Isolation of Antigen-Specific, antibody-Secreting Cells using a Chip-Based Immunospot Array.- Purification of Human Monoclonal antibodies and Their Fragments.- One-Tube Multicolor Flow Cytometry Assay (OTMA) for Comprehensive Immunophenotyping of Peripheral Blood.- Humanization and Simultaneous Optimization of Monoclonal Antibody.- Antibody Fragments Humanization: Beginning with the End in Mind.- Antigen-Specific Human Monoclonal Antibodies from Transgenic Mice.- Refining the Quality of Monoclonal Antibodies: Grafting Unique Peptide-Binding  Site in the Fab Framework.- BasicProcedures for Detection and Cytotoxicity of Chimeric Antigen Receptors.- Rapid Chimerization of Antibodies.- Phage Display Technology for Human Monoclonal Antibodies.- Recombinant Antibody Selections by Combining Phage and Yeast Display.- Epitope Mapping via Phage Display from Single Gene Libraries.- A High-Throughput Magnetic Nanoparticle Based Semi-Automated Antibody Phage Display Biopanning.- A Binding Potency Assay for Pritumumab and Ecto-Domain Vimentin.- A Method to Detect the Binding of Hyper-Glycosylated Fragment Crystallizable (Fc) Region of Human IgG1 to Glycan Receptors.- A Cell-Based Reporter Assay Measuring the Activation of Fc Gamma Receptors Induced by Therapeutic Monoclonal Antibodies.- “BIClonals”: Production of Bispecific Antibodies in IgG Format in Transiently Transfected Mammalian Cells.- Production of Stabilized Antibody Fragments in the E. coli Bacterial Cytoplasm and in Transiently-Transfected Mammalian Cells.